GEN (Genetic Engineering & Biotechnology News)

Recent stories from GEN (Genetic Engineering & Biotechnology News).

GEN (Genetic Engineering & Biotechnology News) Alex Philippidis

Argenx Expands Immunology Capabilities with Up-to-$1.15B UNP Acquisition

The deal is designed to marry UNP’s macrocyclic peptide discovery platform with Argenx’s immunology innovation capabilities to broaden the buyer’s ability to develop oral or long-acting treatments for serious immune-mediated diseases.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Savannah Wiegel

Illumina Offers Early Access to Duplex Sequencing for MRD, Tumor Evolution Research

Illumina has announced an early access program to a duplex sequencing workflow that reads both DNA strands to detect trace ctDNA in molecular residual disease and tumor evolution studies. Kits are expected in early 2027.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Sophia Ktori

How Cancer-Associated Gene Triggers Cell Division Without Unpacking the Genome

A study showed how E2F1 can trigger cell division without having to unpack the cell’s genetic material. Instead, it takes a shortcut path by binding directly to a small area of the DNA that remains tightly packaged inside the cell.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Uduak Thomas

Childhood Cancers May Not Always Need Extra Mutations to Spread, Study Suggests

Childhood cancers may not always need extra mutations to spread, a new review study indicates. Instead, developmental plasticity may let tumor cells shape-shift into states that help them grow, resist treatment, and ultimately metastasize.

Read at GEN (Genetic Engineering & Biotechnology News)

GEN (Genetic Engineering & Biotechnology News) Kathy Vuksanaj

New AI Models Are Turbo-Charging Protein Design

Computer-designed protein therapeutics move from proof-of-concept to wet-lab validation and even clinical trials as the field heats up.

Read at GEN (Genetic Engineering & Biotechnology News)